Literature DB >> 21664402

The burden of hospitalizations for meningococcal infection in Spain (1997-2008).

Ruth Gil-Prieto1, Laura García-García, Alejandro Alvaro-Meca, Alba González-Escalada, Pablo Viguera Ester, Angel Gil De Miguel.   

Abstract

All hospital discharges and deaths related to invasive meningococcal disease, meningococcal meningitis and meningococcemia in the general population from 1997 to 2008 in Spain were obtained. Among the 11,611 meningococcal infection related discharges 53% were meningococcal meningitis and 55% were meningococcemia. The annual hospitalization rate was 2.33, 1.23 and 1.29 cases per 100,000 for invasive meningococcal disease, meningococcal meningitis and meningococcemia, respectively. 846 deaths for invasive meningococcal disease, 235 for meningococcal meningitis and 605 for meningococcemia were reported. Although an important decrease in meningococcal infections related morbidity and mortality has occurred in the last twelve years in Spain, they still continue being major causes of hospitalization and death, especially in the children up to 2 years of age. Future preventive measures, such as vaccination with vaccines covering new conjugated serogroups (B and ACYW135), could further improve population health.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664402     DOI: 10.1016/j.vaccine.2011.05.089

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Risk of hospitalization due to pneumococcal disease in adults in Spain. The CORIENNE study.

Authors:  Ruth Gil-Prieto; Raquel Pascual-Garcia; Stefan Walter; Alejandro Álvaro-Meca; Ángel Gil-De-Miguel
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

2.  Costs of Invasive Meningococcal Disease: A Global Systematic Review.

Authors:  Bing Wang; Renee Santoreneos; Hossein Afzali; Lynne Giles; Helen Marshall
Journal:  Pharmacoeconomics       Date:  2018-10       Impact factor: 4.981

Review 3.  Population-based epidemiology and microbiology of community-onset bloodstream infections.

Authors:  Kevin B Laupland; Deirdre L Church
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

4.  Risk Analysis by Age on the Burden of Meningococcal Disease in Spain.

Authors:  Irene Rivero-Calle; Peter Francis Raguindin; Jacobo Pardo-Seco; Federico Martinon-Torres
Journal:  Vaccines (Basel)       Date:  2022-04-12

5.  Respiratory Syncytial Virus Bronchiolitis in Children up to 5 Years of Age in Spain: Epidemiology and Comorbidities: An Observational Study.

Authors:  Ruth Gil-Prieto; Alba Gonzalez-Escalada; Patricia Marín-García; Carmen Gallardo-Pino; Angel Gil-de-Miguel
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

6.  Invasive Meningococcal Disease: What We Should Know, Before It Comes Back.

Authors:  Carmen Cabellos; Ivan Pelegrín; Eva Benavent; Francesc Gudiol; Fe Tubau; Dolores Garcia-Somoza; Ricard Verdaguer; Javier Ariza; Pedro Fernandez Viladrich
Journal:  Open Forum Infect Dis       Date:  2019-02-07       Impact factor: 3.835

Review 7.  Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.

Authors:  Sandra Guedes; Isabelle Bertrand-Gerentes; Keith Evans; Florence Coste; Philipp Oster
Journal:  BMC Public Health       Date:  2022-02-23       Impact factor: 3.295

8.  Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database.

Authors:  Catherine Weil-Olivier; Muhamed-Kheir Taha; Stéphane Bouée; Corinne Emery; Véronique Loncle-Provot; Gaëlle Nachbaur; Ekkehard Beck; Céline Pribil
Journal:  Hum Vaccin Immunother       Date:  2022-02-22       Impact factor: 3.452

9.  Hospitalizations related to meningococcal infection in Spain from 1997 to 2018.

Authors:  Stefan Walter; Ruth Gil-Prieto; Mario Gil-Conesa; Gil Rodriguez-Caravaca; Jesús San Román; Angel Gil de Miguel
Journal:  BMC Infect Dis       Date:  2021-12-06       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.